ClinicalTrials.gov
public full text
Public Domain
Preoperative Use of Montelukast Sodium
Supraglottic airway equipment used during anaesthesia application can lead to airway reactivity or even larynx spasm in sensitive children. Montelukast Sodium, used in asthma treatment, is a cysteinyl leukotriene Type 1 antagonist which reduces leukotriene C4, leukotriene D4 and leukotriene E4 synthesis. The use of Montelukast Sodium in airway reactivity is known to reduce the need for bronchodilator and corticosteroids.
Conceptio Open Archive
Analyze & explore related research in Conceptio
Connect this record directly into your research workflow or AI agent. Explore citations across open repositories, query full text, and export structured proof bundles.
This document is indexed with metadata only: full text is not available in the archive for this record. Open the official source ↗
Related documents
- Effect of Addition Oral Montelukast to Standard Treatment in Acute Asthma in Hospitalized Preschool Children#1057953
- Effect of Montelukast on the Expression and Variation of TGF-β for Children With Mild Persistent Asthma#812276
- Montelukast in Modulating Exacerbations of Asthma in Children#1102540
- Fractional Concentration of Exhaled NO(FeNO) to Direct The Treatment of Sub-acute Cough#994041
- Sugammadex as Rescue Therapy#878312
Record · ID 900362
Retrieved via Conceptio: every document is proof-bundled with source, license, and retrieval metadata.
Retrieved via Conceptio: every document is proof-bundled with source, license, and retrieval metadata.
Bring this data into your agent: Connect via MCP or API · 20 free credits to start · no card required
Read the Docs → · View CLI source on GitHub · Conceptio Open Knowledge Archive
Read the Docs → · View CLI source on GitHub · Conceptio Open Knowledge Archive